4//SEC Filing
Thomson Mary Christina 4
Accession 0001209191-22-007183
CIK 0001290149other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:08 PM ET
Size
9.2 KB
Accession
0001209191-22-007183
Insider Transaction Report
Form 4
Thomson Mary Christina
General Counsel, CCO & Sec'y
Transactions
- Exercise/Conversion
Common Stock
2022-02-04$13.04/sh+2,000$26,080→ 2,000 total - Sale
Common Stock
2022-02-04$29.78/sh−2,000$59,560→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-02-04+2,000→ 0 totalExercise: $13.04Exp: 2030-07-28→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 21, 2022. The Reporting Person is subject to a Lock-Up Letter Agreement that expires on April 26, 2022. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
- [F2]On July 28, 2021, the option vested as to 25% of the total shares granted on July 28, 2020, with the remaining shares from that grant vesting in equal monthly installments over the following 36 months, with 100% of the total shares vested on July 28, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Sierra Oncology, Inc.
CIK 0001290149
Entity typeother
Related Parties
1- filerCIK 0001295674
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:08 PM ET
- Size
- 9.2 KB